Information Provided By:
Fly News Breaks for November 29, 2018
DXCM
Nov 29, 2018 | 07:45 EDT
JPMorgan analyst Robbie Marcus recommends buying would DexCom into the company's first ever analyst day on December 4. The analyst sees "significant potential upside" to 2019 estimates and a "multi-billion dollar underpenetrated" total addressable market for the company. He believes DexCom has a "clear technological lead" versus peers and reiterates an Overweight rating on the shares with a $165 price target. The stock is his top SMID-cap pick.
News For DXCM From the Last 2 Days
DXCM
DXCM
DXCM
Apr 25, 2024 | 15:11 EDT
Pre-earnings options volume in DexCom is 11.4x normal with calls leading puts 11:2. Implied volatility suggests the market is anticipating a move near 5.8%, or $8.05, after results are released. Median move over the past eight quarters is 5.4%.
DXCM
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.